Found 5 matching trials
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma PHASE1 Phase 1 study comprised of open-label, dose escalation, multiple cohorts of...
Show More Status
Active Not Recruiting
Learn More & Join Trial
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors PHASE1 A Phase 1, open label, dose escalation and expanded cohort study of P-MUC1C...
Show More Status
Active Not Recruiting
Location
University of California, Irvine Medical Center
Learn More & Join Trial
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101 PHASE1 Subjects are enrolled in this study following completion or early discontin...
Show More Status
Active Not Recruiting
Location
University of California Davis
Learn More & Join Trial
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) PHASE1 An open-label, multi-center, single and cyclic ascending dose study of P-PS...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) PHASE1 Phase 1 of the study is comprised of an open-label, single ascending dose (...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial